Study title:
Ilveskoski-I, Saarinen-U-M, Wiklund-T, Perkkioe-M, Salmi-T-T, Lanning-M, Maekipernaa-A, Pihko-H.
Children's Hospital, University of Helsinki, Finland.
Ototoxicity in children with malignant brain tumors treated with the 8 in 1 chemotherapy protocol.
Medical and pediatric oncology, {Med-Pediatr-Oncol}, Jul 1996, vol. 27, no. 1, p. 26-31, ISSN: 0098-1532.Ilveskoski-I, Saarinen-U-M, Wiklund-T, Perkkioe-M, Salmi-T-T, Lanning-M, Maekipernaa-A, Pihko-H.
Children's Hospital, University of Helsinki, Finland.
Ototoxicity in children with malignant brain tumors treated with the 8 in 1 chemotherapy protocol.
Medical and pediatric oncology, {Med-Pediatr-Oncol}, Jul 1996, vol. 27, no. 1, p. 26-31, ISSN: 0098-1532.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|